Jensen, Karen Schow http://orcid.org/0000-0002-0811-8818
Oskarsson, Trausti
Lähteenmäki, Päivi M. http://orcid.org/0000-0002-5500-9606
Flaegstad, Trond
Jónsson, Ólafur Gísli
Svenberg, Petter
Schmiegelow, Kjeld http://orcid.org/0000-0002-0829-4993
Heyman, Mats http://orcid.org/0000-0001-7637-1949
Norén-Nyström, Ulrika http://orcid.org/0000-0001-5606-5442
Schrøder, Henrik
Albertsen, Birgitte Klug http://orcid.org/0000-0002-3902-3694
Funding for this research was provided by:
Kræftens Bekæmpelse (R124-A7831)
A.P. Møller Fonden | Fonden til Lægevidenskabens Fremme (17-L-0462)
Tømrermester Jørgen Holm & Hustru Elisa F. Hansens Foundation
Article History
Received: 28 October 2021
Revised: 11 February 2022
Accepted: 1 March 2022
First Online: 21 March 2022
Competing interests
: BA declares the following: sponsor for the investigator-initiated NOR-GRASPALL 2016 study; speaker and/or advisory board honoraria from Erytech (2020) and Servier (2021). Kjeld Schmiegelow declares the following: speaker and/or advisory board honoraria from Jazz Pharmaceuticals (2020) and Servier (2020); speaker’s fee from Amgen (2020) and Medscape (2020); educational grant from Servier (2020). The remaining authors have no competing interests to declare.